Skip to main content
Clinical Trials/ACTRN12623001178639
ACTRN12623001178639
Recruiting
未知

A prospective pilot study of biofeedback training with Contrain” in patients with major LARS and faecal incontinence symptoms after anterior resection for rectal cancer

niversity of Otago0 sites20 target enrollmentNovember 14, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Faecal Incontinence
Sponsor
niversity of Otago
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 14, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Previous rectal cancer surgery
  • 2\. Full continuity of the gastrointestinal tract (If a stoma was formed it has subsequently been closed at least a year prior to enrolment in this study)
  • 3\. Major LARS (score \> 30\)
  • 4\. Previous treatment has been given for LARS, including medications such as loperamide, dietary advice and treatment for bile acid malabsorption (BAM).
  • 5\. Aged 18\-80
  • 6\. Able to give informed consent
  • 7\. Participant is available to commit to up to 36 weeks of biofeedback training.
  • 8\. Participant is sufficiently motivated to commit to two training sessions a day for 6\-9 months.

Exclusion Criteria

  • Cognitive disorders impeding pelvic floor rehabilitation.

Outcomes

Primary Outcomes

Not specified

Similar Trials